Jason Kelly

Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. Ginkgo Bioworks uses the most advanced technology on the planet – biology – to grow products instead of manufacturing them. Under his leadership, the company has raised over $430M in venture capital to expand their automated genetic engineering foundries and has partnerships with companies including ADM, Cargill, and Cronos. Notably, it announced a joint venture with Bayer to develop microbes to make crops self-fertilizing and launched Motif, an ingredients innovation company pioneering the discovery of better animal-free ingredients. Prior to Ginkgo, Jason received B.S. degrees in Chemical Engineering and Biology and a PhD in Biological Engineering, all from MIT.